BIO, PhRMA Ask Fed. Circ. to Revisit Double-Patent Ruling
July 14, 2014
By: Aaron Vehling
Law360
Axinn associate Thomas Hedemann, who represents Natco, was mentioned in Aaron Vehling's article, "BIO, PhRMA Ask Fed. Circ. to Revisit Double-Patent Ruling," which appeared on Law360.
Click here to access the article. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Axinn Associates at the Antitrust Spring Meeting: Tech-Related Enforcement
Axinn Viewpoints
Antitrust
Axinn Associates at the Antitrust Spring Meeting: AI, Algorithms, and Information Exchange
Axinn Viewpoints
Antitrust
Axinn Associates at the Antitrust Spring Meeting: Perspectives on the DOJ Antitrust Division’s Whistleblower Rewards Program
Axinn Viewpoints
Antitrust
Axinn Associate Maryanne Magnier Appointed to Volunteer Legal Advocates Junior Board
Pro Bono
Axinn Associates at the Antitrust Spring Meeting: Trends in State and Private Enforcement
Axinn Viewpoints
Antitrust
Axinn Associates at the Antitrust Spring Meeting: Sector-Specific Enforcement Trends
Axinn Viewpoints
Antitrust
Conspiracy Theories Newsletter, 2026 Edition
Byline Articles
Antitrust
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
Awards & Recognitions
Antitrust
